Susquehanna International Group
BCTXZ

Susquehanna International Group’s BriaCell Therapeutics Corp Warrant BCTXZ Stock Holding History

Susquehanna International Group’s Portfolio BCTXZ Stock Details BCTXZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Buy
+114,522
New +$11.1K ﹤0.01% 13113

Other funds holding BCTXZ

HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Susquehanna International Group's BCTXZ Position: Q2 2026 in Review

Susquehanna International Group opened a new position in BriaCell Therapeutics Corp Warrant (BCTXZ) in Q2 2026: 114,522 shares worth $11.5K. The stake represents ﹤0.01% of the portfolio and ranks #13113 among its holdings.

5 funds tracked by Wall St. Rank hold BCTXZ as of Q2 2026.

  • Susquehanna International Group held 114,522 shares of BriaCell Therapeutics Corp Warrant worth $11.5K as of Q2 2026.
  • BriaCell Therapeutics Corp Warrant was a new Susquehanna International Group position in Q2 2026.
  • BriaCell Therapeutics Corp Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13113 holding.
  • 5 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.